In an interview with PharmaShots, Ray Lee, CEO at Teclison shared his views on the completion of a $5.9 million capital raise and advancement of its oncology drug portfolio
Shots:
Ray spoke about Teclison’s recently completed funding of $5.9 million led by W.T.T. Investment
He focused on the development of the lead candidate in the…
